Sawada T - Search Results

1

Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer.

Hoshi H, Sawada T, Uchida M, Saito H, Iijima H, Toda-Agetsuma M, Wada T, Yamazoe S, Tanaka H, Kimura K, Kakehashi A, Wei M, Hirakawa K, Wanibuchi H. Hoshi H, et al. Among authors: sawada t. Int J Oncol. 2011 Mar;38(3):619-27. doi: 10.3892/ijo.2011.911. Epub 2011 Jan 18. Int J Oncol. 2011. PMID: 21249315

2

RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.

Yamazoe S, Tanaka H, Sawada T, Amano R, Yamada N, Ohira M, Hirakawa K. Yamazoe S, et al. Among authors: sawada t. J Exp Clin Cancer Res. 2010 May 23;29(1):53. doi: 10.1186/1756-9966-29-53. J Exp Clin Cancer Res. 2010. PMID: 20492722 Free PMC article.

3

Anti-protein-bound polysaccharide-K monoclonal antibody binds the active structure and neutralizes direct antitumor action of the compound.

Hoshi H, Saito H, Iijima H, Uchida M, Wada T, Ito G, Tanaka H, Sawada T, Hirakawa K. Hoshi H, et al. Among authors: sawada t. Oncol Rep. 2011 Apr;25(4):905-13. doi: 10.3892/or.2011.1155. Epub 2011 Jan 19. Oncol Rep. 2011. PMID: 21249323

4

MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways.

Hoshi H, Sawada T, Uchida M, Iijima H, Kimura K, Hirakawa K, Wanibuchi H. Hoshi H, et al. Among authors: sawada t. Int J Oncol. 2013 Mar;42(3):887-93. doi: 10.3892/ijo.2013.1760. Epub 2013 Jan 3. Int J Oncol. 2013. PMID: 23292004

5

A role for protease-activated receptor-2 in pancreatic cancer cell proliferation.

Shimamoto R, Sawada T, Uchima Y, Inoue M, Kimura K, Yamashita Y, Yamada N, Nishihara T, Ohira M, Hirakawa K. Shimamoto R, et al. Among authors: sawada t. Int J Oncol. 2004 Jun;24(6):1401-6. Int J Oncol. 2004. PMID: 15138580

6

Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.

Inoue M, Sawada T, Uchima Y, Kimura K, Nishihara T, Tanaka H, Yashiro M, Yamada N, Ohira M, Hirakawa K. Inoue M, et al. Among authors: sawada t. Oncol Rep. 2005 Dec;14(6):1445-51. Oncol Rep. 2005. PMID: 16273237

7

Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer.

Yamazoe S, Tanaka H, Iwauchi T, Yoshii M, Ito G, Amano R, Yamada N, Sawada T, Ohira M, Hirakawa K. Yamazoe S, et al. Among authors: sawada t. Pancreas. 2011 Aug;40(6):896-904. doi: 10.1097/MPA.0b013e31821ad8d1. Pancreas. 2011. PMID: 21697763

8

Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.

Yamazaki M, Yamashita Y, Kubo N, Yashiro M, Ohira M, Ako E, Tanaka H, Muguruma K, Sawada T, Hirakawa K. Yamazaki M, et al. Among authors: sawada t. Oncol Rep. 2012 Jul;28(1):49-54. doi: 10.3892/or.2012.1803. Epub 2012 May 4. Oncol Rep. 2012. PMID: 22562413

9

Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.

Kimura K, Sawada T, Komatsu M, Inoue M, Muguruma K, Nishihara T, Yamashita Y, Yamada N, Ohira M, Hirakawa K. Kimura K, et al. Among authors: sawada t. Clin Cancer Res. 2006 Aug 15;12(16):4925-32. doi: 10.1158/1078-0432.CCR-06-0544. Clin Cancer Res. 2006. PMID: 16914581

10

Clinical significance of ApoE expression in human gastric cancer.

Sakashita K, Tanaka F, Zhang X, Mimori K, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M. Sakashita K, et al. Among authors: sawada t. Oncol Rep. 2008 Dec;20(6):1313-9. Oncol Rep. 2008. PMID: 19020708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,803 results

Search Page

Filters